Icon

QBREXZA (nda210361)- (EQ 2.4% BASE)

GLYCOPYRRONIUM TOSYLATE JOURNEY
EQ 2.4% BASE
Yes Yes
2033-Feb-28 Expired
None 2021-Jun-28
None No
Qbrexza is an anticholinergic indicated for topical treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older.
0 0 0
Total Other Developers 5
Drugs with Suitability No
EQ 2.4% BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.